The present invention provides salt forms of
(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentyl-
propanenitrile that are useful in the modulation of Janus kinase activity
and are useful in the treatment of diseases related to activity of Janus
kinases including, for example, immune-related diseases, skin disorders,
myeloid proliferative disorders, cancer, and other diseases.